A panel of venture capitalists, advisors and representatives of leading industry organizations discusses the new realities of early stage funding in the life sciences and clean tech sectors. Richard Meadows shares his views on the state of affairs in life sciences venture investing at his firm, CIT Life Sciences.
MaRS - Building Canada’s next generation of global technology companies. marsdd.com
Loading more stuff…
Hmm…it looks like things are taking a while to load. Try again?